Alfa Laval PureBallast near completion of required USCG testing procedures

Alfa Laval remains on track to submit its application for USCG type approval after requisite tests of PureBallast are finished in Q2 of 2016. Half of the required land-based procedures have now been completed using the USCG-approved CMFDA/FDA (staining) method. The tests, which have been performed at DHI in Denmark, have all returned strong biological disinfection results.

"Alfa Laval has a robust biological disinfection technology and has mobilized quickly following the USCG's rejection of most probable number method," says Stephen Westerling Greer, Global Business Manager for PureBallast. "As a dedicated supplier approachi.ng 100 years of marine service, we have made USCG type approval a top priority."

Westerling Greer concludes, "Alfa Laval's vast experience in marine engineering, combined with specific knowledge in the design of ballast water treatment systems, is allowing us to secure a fast and positive testing outcome."